Key Takeaways:
Alibaba Group faces a securities class action over alleged ties to China's military-linked regulator, with a lead plaintiff deadline of Oct. 5, 2026.
"The complaint alleges Alibaba concealed its classification as a Chinese military company and its use of fraudulent accounts to access rival AI models," Reed Kathrein, partner at Hagens Berman, said.
The lawsuit, Wistisen v. Alibaba Group Holding Limited, et al., No. 1:26-cv-06654 (S.D.N.Y.), covers purchasers of American depositary shares between June 26, 2025 and June 24, 2026. It accuses Alibaba and certain executives of violating the Securities Exchange Act of 1934 by failing to disclose that the company was directly or indirectly controlled by or affiliated with China's Ministry of Industry and Information Technology, a classification that placed it within the definition of a Chinese military company under the National Defense Authorization Act. The complaint also alleges Alibaba's risk disclosures flagged other Chinese issuers delisted from the NYSE over military-affiliation concerns while omitting its own exposure.
The truth emerged through two corrective disclosures. On June 8, 2026, the U.S. Department of Defense added Alibaba to its list of Chinese military companies; the ADS fell $4.69, or 3.9 percent, over two sessions to close at $115.38 on June 10. On June 24, Bloomberg reported that Anthropic accused Alibaba of accessing its Claude AI model through nearly 25,000 fraudulent accounts, executing roughly 28.8 million exchanges between April and June 2026 in what the complaint describes as adversarial distillation targeting software engineering and agentic reasoning capabilities. The ADS fell $2.80, or 2.7 percent, to $99.80 on June 24, then a further $4.73, or 4.7 percent, to $95.07 on June 25.
The decline leaves BABA down about $78.61, or roughly 45 percent, from a class-period high of $173.68 recorded Oct. 9, 2025. Investors who purchased during the class period and suffered losses have until Oct. 5, 2026, to ask the court to appoint them lead plaintiff; they need not seek lead plaintiff status to share in any potential recovery. The Private Securities Litigation Reform Act of 1995 governs the action, and lead plaintiffs are typically investors with the largest documented losses. Rosen Law Firm, which first filed the action, is among several firms — including Hagens Berman, Pomerantz, Kaplan Fox and Levi & Korsinsky — soliciting affected shareholders.
The litigation adds legal and regulatory overhang for Alibaba as it competes with U.S. AI developers including Anthropic and OpenAI, and it highlights the scrutiny facing Chinese issuers listed on U.S. exchanges under the NDAA. Investors will watch for the court's lead plaintiff appointment and any settlement or dismissal rulings in the months ahead.
This article is for informational purposes only and does not constitute investment advice.
